The Democrats enabling Trump’s DOJ demolition
In a statement, national security adviser Mike Waltz said that President Donald Trump’s special envoy for the Middle East, ...
Biohaven: NDA Review Of Troriluzole Isn't Only 2025 Catalyst On Deck
Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...
Le Lézard5h
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
AbbVie and Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for ...
The XR market is the perfect place for Samsung to be fun again
A t this point, we may as well admit it; Samsung is no longer fun. The company has given up being the innovative and ...
As college decisions loom, see which California schools are the most selective in the US
One California university topped multiple Ivy League schools for being the second most selective in America, according the ...
CarExpert.com.au on MSN16h
2025 BYD Sealion 7 price and specs
The BYD Sealion 7 has come ashore, priced competitively against a growing throng of Chinese mid-sized electric SUVs.
PipelineReview.com3h
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
SAN DIEGO, CA, USA I 12, 2025 I AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology ...
PipelineReview.com10h
BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM
PALO ALTO, CA, USA I February 11, 2025 I BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused ...